AU2003290342B2 - Metalloprotease proteins - Google Patents

Metalloprotease proteins Download PDF

Info

Publication number
AU2003290342B2
AU2003290342B2 AU2003290342A AU2003290342A AU2003290342B2 AU 2003290342 B2 AU2003290342 B2 AU 2003290342B2 AU 2003290342 A AU2003290342 A AU 2003290342A AU 2003290342 A AU2003290342 A AU 2003290342A AU 2003290342 B2 AU2003290342 B2 AU 2003290342B2
Authority
AU
Australia
Prior art keywords
polypeptide
nucleic acid
disease
disorder
acid molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2003290342A
Other languages
English (en)
Other versions
AU2003290342A1 (en
Inventor
Ursula Boschert
Yolande Chvatchko
Richard Joseph Fagan
Richard James Mitter
Christopher Benjamin Phelps
Christine Power
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ares Trading SA
Original Assignee
Ares Trading SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading SA filed Critical Ares Trading SA
Publication of AU2003290342A1 publication Critical patent/AU2003290342A1/en
Application granted granted Critical
Publication of AU2003290342B2 publication Critical patent/AU2003290342B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
AU2003290342A 2002-12-23 2003-12-23 Metalloprotease proteins Ceased AU2003290342B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0230006.9A GB0230006D0 (en) 2002-12-23 2002-12-23 Proteins
GB0230006.9 2002-12-23
PCT/GB2003/005664 WO2004056983A2 (en) 2002-12-23 2003-12-23 Metalloprotease proteins

Publications (2)

Publication Number Publication Date
AU2003290342A1 AU2003290342A1 (en) 2004-07-14
AU2003290342B2 true AU2003290342B2 (en) 2009-09-24

Family

ID=9950313

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003290342A Ceased AU2003290342B2 (en) 2002-12-23 2003-12-23 Metalloprotease proteins

Country Status (11)

Country Link
US (1) US7557079B2 (enExample)
EP (1) EP1583825B1 (enExample)
JP (1) JP5053516B2 (enExample)
AT (1) ATE526400T1 (enExample)
AU (1) AU2003290342B2 (enExample)
CA (1) CA2510066A1 (enExample)
ES (1) ES2374392T3 (enExample)
GB (1) GB0230006D0 (enExample)
IL (1) IL169256A (enExample)
NO (1) NO20053575L (enExample)
WO (1) WO2004056983A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100183617A1 (en) * 2005-02-23 2010-07-22 University Of Virginia Patent Foundation Compositions and methods for regulating sas1r
GB0921001D0 (en) 2009-11-30 2010-01-13 Aqua Bio Technology Asa Products and uses
CN109957557B (zh) * 2017-12-26 2023-01-06 广州市锐博生物科技有限公司 Dna聚合酶及其制备方法
CN114032252B (zh) * 2021-11-01 2022-04-22 武汉爱博泰克生物科技有限公司 一种重组状态人源mmp-7蛋白的表达方法及应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002066624A2 (en) * 2001-02-20 2002-08-29 Lexicon Genetics Incorporated Novel human protease and polynucleotides encoding the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1311692A2 (en) * 2000-08-23 2003-05-21 Applera Corporation Robert A. Millman Assistant Secretary Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
AU2002336529A1 (en) 2001-09-14 2003-04-01 Incyte Genomics, Inc. Protein modification and maintenance molecules

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002066624A2 (en) * 2001-02-20 2002-08-29 Lexicon Genetics Incorporated Novel human protease and polynucleotides encoding the same

Also Published As

Publication number Publication date
EP1583825B1 (en) 2011-09-28
JP2006516888A (ja) 2006-07-13
ES2374392T3 (es) 2012-02-16
JP5053516B2 (ja) 2012-10-17
IL169256A (en) 2010-11-30
ATE526400T1 (de) 2011-10-15
US7557079B2 (en) 2009-07-07
NO20053575D0 (no) 2005-07-21
EP1583825A2 (en) 2005-10-12
WO2004056983A2 (en) 2004-07-08
WO2004056983A3 (en) 2006-02-09
IL169256A0 (en) 2007-07-04
AU2003290342A1 (en) 2004-07-14
US20060252117A1 (en) 2006-11-09
NO20053575L (no) 2005-09-23
GB0230006D0 (en) 2003-01-29
CA2510066A1 (en) 2004-07-08

Similar Documents

Publication Publication Date Title
AU2016337408B2 (en) Inducible modification of a cell genome
KR101647933B1 (ko) 활성화가능한 기질-분해효소의 생체내 시간적 조절
US20040106778A1 (en) Interferon gamma-like protein
JP5053516B2 (ja) メタロプロテアーゼタンパク質
KR20220023962A (ko) 파브리병을 치료하기 위한 조성물, 디바이스 및 방법
CN115247180A (zh) 试剂盒及其在构建毛囊组织特异表达人源II型5α-还原酶基因的重组猪细胞中的应用
CN115247173B (zh) 构建tmprss6基因突变的缺铁性贫血猪核移植供体细胞的基因编辑系统及其应用
CN115247153B (zh) 用于构建hnf1a基因突变的糖尿病模型猪核移植供体细胞的基因编辑系统及其应用
CN115232817B (zh) 用于构建三基因联合突变的小型猪核移植供体细胞的基因编辑系统及其应用
CN115232793B (zh) 用于构建sod1基因突变的als模型猪核移植供体细胞的基因编辑系统及其应用
KR20230029922A (ko) 피루베이트 키나아제 결핍증(pkd) 유전자 편집 치료 방법
CN115232811B (zh) 用于构建hbb基因突变的镰刀型细胞贫血症模型猪核移植供体细胞的方法及应用
CN115232812B (zh) 一种构建mrap2基因突变的重症早发性肥胖症模型猪核移植供体细胞的方法
CN115247164B (zh) 构建腺瘤性息肉病模型猪及结直肠癌模型猪的基因编辑系统及其应用
CN115232815B (zh) 构建mip基因突变的白内障疾病模型猪核移植供体细胞的基因编辑系统及其应用
CN115232813B (zh) 用于构建vWF基因突变的血管性血友病模型猪核移植供体细胞的基因编辑系统及其应用
CN115232834B (zh) 用于构建oca-1a型白化病模型猪核移植供体细胞的基因编辑系统及其应用
CN115232818B (zh) 构建dok7基因突变的先天性肌无力模型猪核移植供体细胞的基因编辑系统及其应用
CN115232836B (zh) 构建crygc基因突变的先天性白内障模型猪核移植供体细胞的基因编辑系统及其应用
CN115232816B (zh) 用于构建yap1基因突变的白内障模型猪核移植供体细胞的crispr系统及其应用
CN115232794B (zh) 一种基因编辑系统及其在构建oca-1b型白化病模型猪核移植供体细胞中的应用
CN115161335B (zh) 用于构建tardbp基因突变的als模型猪核移植供体细胞的基因编辑系统及其应用
CN115232796B (zh) 构建mkrn3基因突变的中枢性性早熟模型猪核移植供体细胞的基因编辑系统及其应用
US20030154499A1 (en) Mouse unable to express functional alpha-4 integrin protein, and methods for assaying compounds or agents for alpha-4 integrin protein antagonist activity and a genetic marker for evaluating efficacy of modulators of signaling activity of a VLA-4 receptor
HK40099652A (en) Pyruvate kinase deficiency (pkd) gene editing treatment method

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired